title: The failure of the ACCLAIM trial is due to an irrational technology.
abstract: The excessive blood oxidation devised with the Celacade System does not procure any advantage in chronic heart failure's patients. The irrationality of the procedure delays a therapeutic advantage and ought to be fully revised.
authors.forename: Velio
authors.initials: V
authors.lastname: Bocci
mesh_terms: D002908:Chronic Disease; D006333:Heart Failure / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D010083:Oxidants, Photochemical / Q000627:therapeutic use; D018384:Oxidative Stress / Q000502:physiology; D010126:Ozone / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic / Q000379:methods* / Q000592:standards; D017211:Treatment Failure
chemical_list: D010083:Oxidants, Photochemical; D010126:Ozone